
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple day:
Sigma-Aldrich profits edge upwards after slight sales uptick
Sigma-Aldrich Corp. (NSDQ:SIAL) reported profits of $94 million, or 76 cents per diluted share, on sales of $582 million during the three months ended Dec. 31. That compares with profits of $93 million, or 75 cents per diluted share, on sales of $573 million during the same period last year.
Read more
Charles River Labs losses soar past $300 million after goodwill hit
Charles River Laboratories International Inc. (NYSE:CRL) reported a loss of $343.6 million or $6.04 per diluted share, on sales of $281.7 million during the three months ended Dec. 25. That compares with a profit of about $17.6 million, or 27 cents per diluted share, on sales of $290.0 million during the same period last year.
Read more
pSivida sinks deeper into the red with just 12 percent of 2009’s sales
pSivida Corp. (NSDQ:PSDV) reported a loss of of $2.7 million, or 15 cents per diluted share, on sales of about $414,000 during the three months ended Dec. 31. That compares with a loss of $24,000, less than 0 cents per diluted share, on sales of $3.4 million during the same period last year.
Read more
Misonix sales rise, but company dips into the red
Misonix Inc. (NSDQ:MSON) reported a loss of $536,166, or 8 cents per diluted share, on revenue of $3.4 million during the three months ended Dec. 31. That compares with a profit of $223,713, or 3 cents per diluted share, on revenue of $3.1 million during the same period last year.
Read more
Clinical Data losses shrink as company logs revenue
Clinical Data Inc. (NSDQ:CLDA) reported a loss of $5.2 million, or 17 cents per diluted share, on sales of $2.0 million during the three months ended Dec. 31. That compares with a loss of $16.0 million, or 63 cents per diluted share, no revenue during the same period last year.
Read more